Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

145.94 -0.45 (-0.31%)
Official Closing Price Updated: 4:10 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
FDA Approves Zoetis' Solensia To Control Osteoarthritis Pain In Cats
The FDA has approved Zoetis Inc's (NYSE: ZTS) Solensia (frunevetmab injection) to control the pain of osteoarthritis (OA) in cats, helping improve their... 
Via Benzinga
Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats
From Zoetis Inc.
Via Business Wire
Zoetis Announces Expanded Commitments to Protect the Planet
From Zoetis Inc.
Via Business Wire
4 Top Stock Trades for Wednesday: AVGO, AMD, ARKK, ZTS
Advanced Micro Devices, Broadcom, the ARKK ETF and Zoetis were our top stock trades for Wednesday. Now, let's take a look at the charts. 
Via InvestorPlace
Why This Petcare Stock Is Hitting Record Highs
The pet care sector was already growing rapidly, but the coronavirus pandemic has only accelerated its growth. 
Via Talk Markets
Zoetis to Participate in the 40th Annual J.P. Morgan Healthcare Conference
From Zoetis Inc.
Via Business Wire
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2021 Financial Results
From Zoetis Inc.
Via Business Wire
Price To Earnings Ratio Insights For Zoetis
In the current session, Zoetis Inc. (NYSE:ZTS) is trading at $229.83, after a 1.83% increase. Over the past month, the stock increased by 6.13%, and in the past year... 
Via Benzinga
Zoetis Raises FY22 Dividend By 30%, Announces New Buyback Program Of $3.5B
The board of directors of Zoetis Inc (NYSE: ZTS) has approved a $3.5 billion share repurchase program. The company added that the new share buyback, spanning... 
Via Benzinga
Zoetis Announces Authorization of $3.5 Billion Share Repurchase Program
From Zoetis Inc.
Via Business Wire
Zoetis Named One of Newsweek’s Most Responsible Companies for 2022
From Zoetis Inc.
Via Business Wire
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 5 Years
Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 19.02% on an annualized basis. Buying $100.00 In ZTS: 5 years ago, an investor could have purchased 2.01... 
Via Benzinga
The ProShares Pet Care ETF Capitalizes on Our Love for Our Pets
Our little furry friends are part of an industry projected to be worth $350 billion by 2027. That's where the PAWZ ETF comes in. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021
Upgrades Macquarie upgraded the previous rating for ZTO Express (Cayman) Inc (NYSE: 
Via Benzinga
Zoetis inc (ZTS) Q3 2021 Earnings Call Transcript
ZTS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Zoetis Extends Its Breakout As Fido's Drugmaker Beats Quarterly Forecasts
Zoetis also issued better-than-expected guidance for 2021. 
Via Investor's Business Daily
Zoetis Announces Third Quarter 2021 Results
From Zoetis Inc.
Via Business Wire
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion. • Cars.com... 
Via Benzinga
Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health
From Zoetis Inc.
Via Business Wire
Zoetis Declares Fourth Quarter 2021 Dividend
From Zoetis Inc.
Via Business Wire
Zoetis to Host Webcast and Conference Call on Third Quarter 2021 Financial Results
From Zoetis Inc.
Via Business Wire
Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount
From Zoetis Inc.
Via Business Wire
Cramer Weighs In On Lennar, Alibaba And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he needs something less speculative than Original BARK Co (NYSE: BARK). He suggested Zoetis Inc (NYSE: ZTS),... 
Via Benzinga
4 Top Healthcare Stocks to Buy in September
In addition to playing a major role in helping the world fight the COVID-19 pandemic, the healthcare industry is making solid progress in addressing the rising health issues faced by an aging global... 
Via Talk Markets
Zoetis to Participate in the Jefferies Virtual Pet Care Summit
From Zoetis Inc.
Via Business Wire
'Fast Money Halftime Report' Picks For September 8
On CNBC's "Fast Money Halftime Report," Jon Najarian said the October $65 calls and the October $70 calls in Bristol-Myers Squibb Co (NYSE: BMY) were extremely... 
Via Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high... 
Via Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.